✦ LIBER ✦

Symposia in chromatography: Where do we stand and where are we heading?

✍ Scribed by Bertsch, Wolfgang

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 119 KB
Volume: 12
Category: Article
ISSN: 0935-6304
DOI: 10.1002/jhrc.1240120602

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorials. Chemotherapy trials in head

Editorials. Chemotherapy trials in head and neck cancer: Where are we, and where are we going?

✍ Randal S. Weber 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Islet transplantation: where do we stand

Islet transplantation: where do we stand now?

✍ Boaz Hirshberg; Kristina I. Rother; David M. Harlan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Catastrophic antiphospholipid syndrome:

Catastrophic antiphospholipid syndrome: Where do we stand?

✍ Doruk Erkan; Ricard Cervera; Ronald A. Asherson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

QM/MM: What Have We Learned, Where Are W

QM/MM: What Have We Learned, Where Are We, and Where Do We Go from Here?

✍ Hai Lin; Donald G. Truhlar 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB 👁 2 views

Alcohol and breast cancer. Where are we

Alcohol and breast cancer. Where are we now where do we go from here?

✍ Arthur Schafzkin; Matthew P. Longnecker 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Where do we stand with hepatoblastoma? :

Where do we stand with hepatoblastoma? : A review

✍ J. Marco Schnater; S. Eleonore Köhler; Wouter H. Lamers; Dietrich von Schweinitz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract Hepatoblastoma (HB) is the most common pediatric liver malignancy, comprising approximately 1% of all pediatric cancers. The disparate clinical staging systems and histologic classifications that were developed during the last decades, nevertheless, reflect the remaining difficulties an